๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for GLP-1

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity NCT07136714Phase 41 site๐Ÿ“ Hillerรธd Nordsjaellands Hospital ยท Tests: Semaglutide Injectable Product, Placebo GLP-1R Actions on Muscle and the Skeleton NCT07154719Phase 42 sites๐Ÿ“ Baton Rouge๐Ÿ“ Scarborough Pennington Biomedical Research Center ยท Tests: Tirzepatide, Lifestyle toolkit Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV NCT04174755NA1 site๐Ÿ“ Dublin University College Dublin ยท Tests: Semaglutide Injectable Product, Standard of care Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents NCT07693426Phase 15 sites๐Ÿ“ Beijing๐Ÿ“ Wuhan๐Ÿ“ Shenyang Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. ยท Tests: Efsubaglutide Alfa 5 mg QW, Efsubaglutide Alfa 10 mg QW, Efsubaglutide Alfa 20 mg QW, Efsubaglutide Alfa placebo Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation NCT07387796NA1 site๐Ÿ“ Dallas The University of Texas at Dallas ยท Tests: Discontinuation and Reinitiation of Tirzepatide Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) NCT07083154Phase 38 sites๐Ÿ“ Changsha๐Ÿ“ Changzhou๐Ÿ“ Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ ยท Tests: Mazdutide, Placebo Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment NCT07457437NA1 site๐Ÿ“ Exeter University of Exeter ยท Tests: Progressive Resistance Exercise Training Program, Habitual physical activity guidelines Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication NCT06843512n/a1 site๐Ÿ“ State College Penn State University ยท Tests: GLP-1 Medication Initiation The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients NCT05938712Phase 21 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes NCT07685808Phase 221 sites๐Ÿ“ Mobile๐Ÿ“ Walnut Creek๐Ÿ“ Waterbury Regeneron Pharmaceuticals ยท Tests: Olatorepatide, Placebo Mechanisms of Weight Loss: Tirzepatide vs Semaglutide NCT07900074Phase 41 site๐Ÿ“ Hamilton McMaster University ยท Tests: Tirzepatide, Semaglutide IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion NCT07361874NA1 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Intervention 1: Adrenalectomy, Intervention 2: Semaglutide The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Parameters of the Diet as Well as Metabolic and Behavioral Parameters in Patients With Excess Body Weight NCT07270497n/a1 site๐Ÿ“ Warsaw Medical University of Warsaw Development of a Non-invasive Method for Quantifying Cerebral Glucose Metabolism for Studying the Effect of Glucagon in Humans NCT06647368NA1 site๐Ÿ“ Copenhagen Nicolai Jacob Wewer Albrechtsen ยท Tests: PET with 18-FDG Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists NCT07803185n/a1 site๐Ÿ“ Kayseri TC Erciyes University Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults NCT07513168Phase 41 site๐Ÿ“ Hyderฤbฤd Asian Institute Of Medical Sciences ยท Tests: Locally available low-dose semaglutide (0.25 mg, 0.5 mg, 1 mg) GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM NCT07314684Phase 42 sites๐Ÿ“ Caserta๐Ÿ“ Naples Federico II University ยท Tests: semaglutide, Standard Treatment (Guideline-Based) Bariatric Surgery Combined With GLP-1RA: A Multicenter Study. NCT07732738NA7 sites๐Ÿ“ Xingtai๐Ÿ“ Zhengzhou๐Ÿ“ Baotou China-Japan Friendship Hospital ยท Tests: BS-GLP1RA group, BS group A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar NCT07284511Phase 2, Phase 34 sites๐Ÿ“ Montreal๐Ÿ“ Montreal๐Ÿ“ Montreal McGill University Health Centre/Research Institute of the Mโ€ฆ ยท Tests: Tirzepatide, Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM), Carbohydrate Counting, No Meal Aโ€ฆ Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes NCT07210684NA1 site๐Ÿ“ Addison Nanjing Nutrabuilding Bio-tech Co., Ltd. ยท Tests: Placebo 400 mg, Dihydroberberine๏ผˆDHB๏ผ‰400 mg Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight NCT07467447Phase 21 site๐Ÿ“ Shenzhen Hudson Biotech ยท Tests: Retatrutide (LY3437943), Placebo, Standardized diet and physical activity counseling throughout the study. Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment NCT07226947NA1 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Smartwatch activity and body composition monitor, General guidance on recommended exercise OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme NCT07779343NA1 site๐Ÿ“ Algiers University of Health Sciences, Algeria ยท Tests: Semaglutide (Wegovy) weekly injection, Behavioral Treatment, Weight loss Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes NCT07835360n/a2 sites๐Ÿ“ Mexico City๐Ÿ“ Mexico City Instituto Nacional de Ciencias Medicas y Nutricion Salvadorโ€ฆ Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction NCT07178145Phase 41 site๐Ÿ“ Charlottesville University of Virginia ยท Tests: GLP-1RA Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder NCT07213466Phase 41 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Group Therapy Program, semaglutide, Phentermine-Topiramate, naltrexone and bupropion (combination) Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events NCT07607587Phase 113 sites๐Ÿ“ Walnut Creek๐Ÿ“ Fleming Island๐Ÿ“ Jacksonville Novo Nordisk A/S ยท Tests: Cagrilintide, Placebo (matched to Cagrilintide) Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study NCT07676565n/a17 sites๐Ÿ“ Newport Beach๐Ÿ“ San Francisco๐Ÿ“ Miami Indiana University Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes NCT05822609Phase 24 sites๐Ÿ“ Aurora๐Ÿ“ Seattle๐Ÿ“ Spokane University of Washington ยท Tests: Semaglutide, Placebo Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284Phase 42 sites๐Ÿ“ San Antonio๐Ÿ“ San Antonio Marzieh Salehi ยท Tests: Semaglutide Injectable Product, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy